ロード中...
Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart(®) in patients with multiple sclerosis
BACKGROUND: Adherence to disease-modifying drugs (DMDs) is one of the key factors for achieving optimal clinical outcomes. Rebismart(®) is an injection device for subcutaneous administration of interferon beta-1a (INF β-1a) that is also able to monitor adherence objectively. The aim of this study wa...
保存先:
| 出版年: | Patient Prefer Adherence |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5338953/ https://ncbi.nlm.nih.gov/pubmed/28280313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S127508 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|